Qube Research & Technologies (QRT)
CTKB icon

Qube Research & Technologies (QRT)’s Cytek Biosciences CTKB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,573
Closed -$78.5K – 3600
2025
Q1 		$78.5K Buy
+19,573
New +$101K ﹤0.01% 3039
2023
Q2 		– Sell
-128,574
Closed -$1.18M – 2486
2023
Q1 		$1.18M Buy
128,574
+17,026
+15% +$183K 0.01% 1222
2022
Q4 		$1.14M Buy
+111,548
New +$1.5M 0.01% 1172

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CTKB Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Cytek Biosciences (CTKB) in Q2 2025, closing a stake of 19,573 shares — an estimated $78.5K sold.

Qube Research & Technologies (QRT) first reported a position in CTKB in Q4 2022 and held it in 3 quarters. The position peaked at $1.18M in Q1 2023. 158 funds tracked by Wall St. Rank hold CTKB as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Cytek Biosciences position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,573 Cytek Biosciences shares in Q2 2025, an estimated $78.5K.
  • Qube Research & Technologies (QRT) first reported a position in Cytek Biosciences in Q4 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Cytek Biosciences position peaked at $1.18M in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.